ABcann & Cannabis Wheaton Sign Win-Win Deal to Expand

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
219
ABcann & Cannabis Wheaton Sign Win-Win Deal to Expand Production -- CFN Media

SEATTLE, WA--(Marketwired - Jun 2, 2017) - CFN Media Group ("CFN Media"), the leading agency and digital media network dedicated to legal cannabis, today announced publication of an article covering ABcann Global Corp.'s ( TSX VENTURE : ABCN ) binding interim agreement with Cannabis Wheaton Income Corp. ( TSX VENTURE : CBW ) and why it marks a significant turning point for both companies.

New Cultivation Facility

ABcann is a globally-licensed, cost-efficient producer of premium quality, organic, standardized medicinal cannabis under the Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR). Over the past few years, the company has invested over $1.5 million in a partnership with the University of Guelph to perfect controlled environmental systems capable of producing pharmaceutical-grade cannabis without pesticides at double the average industry yield.

The company's phase one facility is a 14,500 square foot facility, known as the Vanluven Facility, that's already operational and producing 1,000 kilograms of dried cannabis per year. ABcann is currently doubling Vanluven to about 30,000 square feet. Concurrently, the company is building a 100,000 square foot facility -- known as the Kimmett Facility -- in Napanee, Ontario with production capacity of about 20,000 kilograms per year. All of this construction and expansion is currently funded and owned by ABcann Global.

On May 29, the company announced a deal whereby Cannabis Wheaton agreed to invest $30 million into ABcann (helping with the current operations and expansion to 130,000 square feet). Cannabis Wheaton further committed, pending some conditions and the completion of the initial $30 million equity investment, to fully fund the construction of an additional 50,000 square feet worth of the Kimmett Facility at some point in the future. The proceeds (minus certain costs) from this new 50,000 sf production area would be split 50-50 between the two companies.

The 180,000 square feet of funded production capacity sets ABcann near the top of the licensed producer pile in that metric. The first $15 million investment is being made by June 30th, 2017 at C$2.25 per share, with the second $15 million committed at C$2.25 or 2x the ten day average for the stock at the time (as late as March, 2018), whichever is greater. This pricing represents a significant premium to the current price of C$1.00 per share. But even assuming a C$2.25 per share valuation -- or roughly C$226 million, the company still represents a compelling value in the industry with some licensed producers commanding valuations two to four times higher.

First Streaming Deal

Cannabis Wheaton is the world's first cannabis streaming company with 15 agreements across six provinces to fund facility construction, expansion, and innovations in exchange for minor equity interests and portions of the cultivation production. For investors, this means access to the high-margin upside of multiple cultivation facilities without the many risks associated with owning bricks and mortar -- or highly-diversified operations, in other words.

Under its agreement with ABcann, Cannabis Wheaton will receive 50% of the net proceeds of future wholesale or retail sales completed by ABcann with respect to cannabis produced in the new 50,000 sf portion of the Kimmett facility. Management estimates this to be roughly eight million grams of cannabis per year, which translates to about $40 million at $5 per gram. The company will also retain a minority equity interest in ABcann and become a strategic partner.

ABcann will be the sixth licensed producer in Cannabis Wheaton's portfolio, but it's their first publicly-traded producer with a sales license. This represents a key turning point for Cannabis Wheaton after just recently becoming a publicly-traded company itself. The deal is highly attractive and could provide internal rates of return in excess of 50% without any consideration for equity, as well as serve as a model for future agreements with public companies.

Please follow the link to read the full article: http://www.cannabisfn.com/abcann-cannabis-whe...roduction/

Learn how to become a CFN Media featured company, brand or entrepreneur: http://www.cannabisfn.com/become-featured-company/

Download the CFN Media iOS mobile app to access the world of cannabis from your smart phone: https://itunes.apple.com/us/app/cannabisfn/id...?ls=1&mt=8

Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone: http://www.cannabisfn.com

About CFN Media CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.

Disclaimer: Except for the historical information presented herein, matters discussed in this release contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC, which owns CFN Media and CannabisFN.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/ .

Contact: Frank Lane President, CFN Media Group (206) 369-7050 flane@cannabisfn.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 5

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Smart Living Solutions Unveiled by Hisense at CES 2026

Updated Category News Views 136

Hisense Unveils Smart Living Innovations at CES 2026 Hisense has made headlines once again at CES 2026 by presenting an impressive array of smart living solutions that integrate seamlessly into everyday life. The company, recognized worldwide for its prowess in consumer electronics and home appliances, demonstrated its commitment to enhancing modern living through...

Continue Reading
Exploring the Innovations of Oncotelic Therapeutics Inc.

Updated Category News Views 103

Oncotelic Therapeutics: A Leader in Cancer Innovations Oncotelic Therapeutics Inc. (NASDAQ: OTLC), a pioneering clinical-stage biopharmaceutical company, is committed to advancing groundbreaking therapies in oncology and immunotherapy. The organization specializes in developing innovative treatments for difficult-to-treat cancers and rare diseases. This vision is...

Continue Reading
Introducing EMBREY Insights: A New Perspective on Investments

Updated Category News Views 128

Introducing EMBREY Insights: A New Publication for Investors New Publication Focuses on the Emerging Strength of Multifamily Investments EMBREY, a vertically integrated real estate investment company, recently announced the launch of its latest research periodical, EMBREY Insights. This new publication aims to deliver expert research and insights on multifamily investment...

Continue Reading
Oportun's Strategic Alliance with Findell Capital Management

Updated Category News Views 105

Oportun Enters Strategic Cooperation Agreement Oportun Financial Corporation (Nasdaq: OPRT), a dedicated financial services firm, has embarked on a groundbreaking journey by entering a multi-year cooperation agreement with Findell Capital Management LLC. This collaborative move marks a significant milestone in maintaining harmonious relations within the company’s...

Continue Reading
Nutricosmetics Market Expected to Surpass $15 Billion by 2033

Updated Category News Views 174

Nutricosmetics Market Overview The global nutricosmetics market is on a trajectory for substantial growth, with projections estimating a rise from USD 8.28 billion in the near future to USD 15.36 billion by 2033. According to industry insights, this growth represents a compound annual growth rate (CAGR) of 8.07% from 2026 to 2033. The increasing awareness regarding the...

Continue Reading